iXensor Co (ROCO:6734) 1-Year Sharpe Ratio: -0.13 (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6734 iXensor Co Ltd ROCO:6734
48 GF Score
Price NT$5.62
GF Value NT$5.38
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is iXensor Co 1-Year Sharpe Ratio?

iXensor Co ROCO:6734 +0.36% 48 1-Year Sharpe Ratio is -0.13 as of Sep. 21, 2026. GuruFocus rates ROCO:6734 with a GF Score™ of 48/100 and a GF Value™ of NT$5.38 (Fairly Valued). The stock has 5 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-09-21), iXensor Co's 1-Year Sharpe Ratio is -0.13.

iXensor Co  (ROCO:6734) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

iXensor Co 1-Year Sharpe Ratio Related Terms

ROCO:6734 vs ABT, SYK, MDT: 1-Year Sharpe Ratio Comparison

For the Medical Devices subindustry, iXensor Co's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iXensor Co 1-Year Sharpe Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iXensor Co's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where iXensor Co's 1-Year Sharpe Ratio falls into.


ROCO:6734
48GF Score
iXensor Co Ltd ROCO:6734
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iXensor Co 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -0.13 mean?
iXensor Co (ROCO:6734) has a 1-Year Sharpe Ratio of -0.13 as of Sep. 21, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for iXensor Co and its competitors.
Is iXensor Co's 1-Year Sharpe Ratio too high?
iXensor Co's current 1-Year Sharpe Ratio is -0.13. Overall, iXensor Co has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does iXensor Co's 1-Year Sharpe Ratio compare to ABT and SYK?
iXensor Co's 1-Year Sharpe Ratio of -0.13 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Medical Devices & Instruments company?
A good 1-Year Sharpe Ratio depends on the Medical Devices & Instruments industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for iXensor Co and its competitors. iXensor Co's current 1-Year Sharpe Ratio is -0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iXensor Co stock overvalued right now?
Based on GuruFocus' analysis, iXensor Co (ROCO:6734) is currently considered Fairly Valued. The stock's GF Value™ is NT$5.38, compared to a current price of NT$5.62 — trading 4.5% above its estimated fair value. The current 1-Year Sharpe Ratio is -0.13. iXensor Co's overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For iXensor Co (ROCO:6734), the current 1-Year Sharpe Ratio is -0.13 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iXensor Co (ROCO:6734) Overvalued in 2026?

Based on GuruFocus' analysis, iXensor Co stock appears to be overvalued. The current stock price of NT$5.62 is trading 4.5% above its estimated GF Value™ of NT$5.38. GuruFocus considers iXensor Co to be Fairly Valued.

Key valuation signals for ROCO:6734:

  • 1-Year Sharpe Ratio: -0.13
  • GF Value™: NT$5.38 vs. price of NT$5.62 (4.5% above fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the ROCO:6734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iXensor Co Business Description

Address No. 9, Lane 2, Lane 35, Jihu Road, 6th Floor, Neihu District, Taipei, TWN, 11492
iXensor Co Ltd is a Taiwan based company involved in research and development, manufacturing and sales of medical equipment. Its PixoTest technology utilizes the lighting and image sensing module of the smartphone or mobile device to detect the color change reaction on the biochemical test strip. This enables the users to monitor their conditions of diabetes, cardiovascular diseases, women health problems, or infectious diseases.
48GF Score

Get the complete analysis for ROCO:6734

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$5.62
Price
NT$5.38
GF Value